Prospective multi-center trial for diVa vaginal laser for Atrophic Vaginitis. Lead Investigator and Protocol developer.
August 2016 – present.
Prospective multi-center trial for diVa vaginal laser for Stress Urinary Incontinence. Lead Investigator and Protocol developer.
August 2016 – present.
Ministop single incision sling pilot U.S. trial. CL Medical.
May 2015 – present. Lead investigator and protocol developer.
I-stop retropubic and transobturator sling U.S. database.
May 2015 – present. Developed and house database. CL Medical
Y for Her: RCT of Upsylon vs. Restorelle Y mesh for Robotic ASC. Lead Investigator and Protocol developer.
December 2014 – present
Amphora RF for OAB Treatment.
May 2015 – Present. Investigator
ROSE Study: Macroplastique for Treatment of SUI. Investigator.
March 2014 – present
AMS ISPRINT perineal support device.
October 2012-present. Investigator
EMBRACE Trial: FDA 522 Analysis for Anterior Elevate.
January 2015 – present. Investigator and Protocol developer
HARMONY Trial: FDA 522 Analysis for Posterior Elevate.
January 2015 – present. Investigator and Protocol developer
AMS Capture Postmarket Anaylsis: MiniarcPro.
Feb 2013 – Present. Investigator.
Altis Minisling Prospective Study.
August 2011 – Present. Investigator
Floroscopic Evaluation of Vaginal Axis with Five Vault Suspension Techniques Compared to Normal.
October 2008 Primary Investigator
MiniarcTM sling: Long-term effectiveness trial.
Oct 2007 Primary Investigator
A Randomized, Evaluator-blinded, Multi-center Study Comparing the Efficacy and Safety of ZUIDEXTM with Contigen® in Female Patients with Stress Urinary Incontinence.
June 2004 – July 2005. Investigator.
Open Label Study of the Efficacy and Safety of 5 and 10 mg Vesicare™ in Patients with Overactive Bladder Symptoms.
June 2004 – July 2005. Investigator.
Prospective, Randomized Veritas™ Collagen Matrix for Cystocele Repair Post-marketing Study.
August 2003 – Present. Investigator.
A Multicenter Evaluation of the Kolpexin™ Vaginal Spheres in Females with Vaginal Prolapse.
December 2001 – July 2005. Investigator.
A United States Multi-Center Prospective Study of the Utility and Effectiveness of the American Medical Systems Subfascial Hammock.
August 2003 – July 2005. Sub-investigator.
Assessment of the Efficacy of Tolterodine ER Versus Placebo for the Symptom of Urgency and The Improvement in Bladder Condition.
September 2002 – June 2003. Sub-investigator.
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study of Oxybutynin Transdermal Systems in Patients with Overactive Bladder.
August 2003 – October 2003. Sub-Investigator.
Clinical Investigation of an Adjustable Continence Therapy (ACT) Periurethral Prosthetic System for Treatment of Female Stress Urinary Incontinence with or without Hypermobility.
September 2002- July 2005. Sub-investigator.
Randomized, Double-Blind, Placebo-Controlled, Dose-finding Study to Evaluate the Effects of a Partial Alpha1A/1L-Adrenoceptor Antagonist, Ro115-1240, in Women with Stress Urinary Incontinence or Mixed Urinary Incontinence.
February 2002 – February 2004. Sub-investigator.
Open-Label Extension for Treatment of Incontinent Patients Who Have Completed the Ro115-1240 Study. August 2002 – June 2004. Sub-investigator.
A Prospective, Double-Blind, Randomized Study of the Effect of Premarin Vaginal Cream and Low-Dose Premarin/MPA on Dyspareunia, Atrophic Vaginitis, Sexual Function, Quality of Life, and Genital Blood Flow
April 2001 – September 2003. Sub-investigator.
Phase III, Multinational, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Transdermal Testosterone (300 mg/day) for 24 Weeks and Safety for a further 28 weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Concurrent Oral Hormone Replacement Therapy.
March 2002 – July 2005. Sub-investigator. Prospective, Non-Randomized Pilot Study to Evaluate Polymer Technologies, Inc.’s Polymer 47K Urethral Bulking Agent Implant to Treat Stress Urinary Incontinence. June 2000 – July 2005. Sub-investigator.
Effects of estrogen on Protein Synthesis in Arteries. Women’s Health Initiative Study. Research Division, AHA, University of Vermont.
1992-93. Student investigator
"I think the thing that stood out most about the office is that I really felt like, Dr. Guerette understood what I was talking about when I started talking about some of the bladder issues I had. And number two,everybody just seemed really very caring. I really appreciated that."
"I would recommend Dr. G and Jennifer because they are the best. They listen, they're very patient and they really know their stuff! I would like to add that since I have, found Dr. G and Jennifer, I have learned a lot about myself and what I'm going through, that I'm not the only one and there's help so don't have to suffer in silence any longer."
"When I was here, I felt completely heard. I felt, seen and understood. You guys really helped me. You made me not feel, you made me feel like a human. You didn't make me feel like I was a patient."
"I have a much better idea of what's going on with my body and the things that I need to do to, help be more comfortable, have a better quality of life."
